ConductScience.org, home

Paper3918967

Combination of external beam irradiation and multiple-site perineal applicator (MUPIT) for treatment of locally advanced or recurrent prostatic, anorectal, and gynecologic malignancies.

Martinez A and 4 others. Int J Radiat Oncol Biol Phys, 1985. Cited by 79 papers, by iCite.

Cite this record

ConductScience Library. Combination of external beam irradiation and multiple-site perineal applicator (MUPIT) for treatment of locally advanced or recurrent prostatic, anorectal, and gynecologic malignancies. Papers, record 3918967. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3918967

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Combination of external beam irradiation and multiple-site perineal applicator (MUPIT) for treatment of locally advanced or recurrent prostatic, anorectal, and gynecologic malignancies.
PubMed
Journal
Int J Radiat Oncol Biol Phys
PubMed
Year
1985
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
79
iCite
Relative citation ratio, by iCite
5.36
iCite
Revised in PubMed
2019-07-08
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Martinez AA
2Edmundson GKG K
3Cox RSR S
4Gunderson LLL L
5Howes AEA E

Source PubMed

Download CSV of authors

Topics21

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BrachytherapyMajor topic
Prostatic NeoplasmsMajor topic
Rectal NeoplasmsMajor topic
Uterine Cervical NeoplasmsMajor topic
Vaginal NeoplasmsMajor topic
Adenocarcinoma
Adolescent
Adult
Aged
Anus Neoplasms
Carcinoma, Squamous Cell
Female
Humans
Iridium
Male
Middle Aged
Neoplasm Recurrence, Local
Particle Accelerators
Radioisotopes
Radiotherapy, High-Energy
Urethral Neoplasms

Source PubMed

Download CSV of topics

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 79 citations.

PMIDTitleJournalYearIn PapersSource
35261493Evolution of Brachytherapy Applicators for the Treatment of Cervical Cancer.J Med Phys2021https://conductscience.org/library/papers/35261493PubMed
30989088Intraoperative 360-deg three-dimensional transvaginal ultrasound during needle insertions for high-dose-rate transperineal interstitial gynecologic brachytherapy of vaginal tumors.J Med Imaging (Bellingham)2019https://conductscience.org/library/papers/30989088PubMed
27895683
Salvage interstitial brachytherapy based on computed tomography for recurrent cervical cancer after radical hysterectomy and adjuvant radiation therapy: case presentations and introduction of the technique.
J Contemp Brachytherapy2016https://conductscience.org/library/papers/27895683PubMed
26894355A specially designed domed-cones template for needles (seeds) fixation and incline insertion in prostate implant brachytherapy.J Appl Clin Med Phys2016https://conductscience.org/library/papers/26894355PubMed
25097564MRI findings at image guided adaptive cervix cancer brachytherapy: radiation oncologist's perspective.J Contemp Brachytherapy2014https://conductscience.org/library/papers/25097564PubMed
24456669Vaginal tolerance of CT based image-guided high-dose rate interstitial brachytherapy for gynecological malignancies.Radiat Oncol2014https://conductscience.org/library/papers/24456669PubMed
23297319High-dose-rate interstitial brachytherapy for gynecologic malignancies--dosimetric changes during treatment period.J Radiat Res2013https://conductscience.org/library/papers/23297319PubMed
16985869Advances in brachytherapy.Rev Urol2004https://conductscience.org/library/papers/16985869PubMed
8024357Recurrent squamous cell carcinoma of the anal canal. Predictors of initial treatment failure and results of salvage therapy.Ann Surg1994https://conductscience.org/library/papers/8024357PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3918967

GET https://conductscience.org/api/papers/v1/3918967/authors